Tag: PCTL

Incredible Options Trading Week!

Another Big Options Trading Week
–
UnitedHealth Group, Inc. UNH – We were just reporting on the solid gains made by our UNH idea yesterday, the UNH Weekly $270-277.50 Calls. It was a see-saw kind of a day for the markets at large, but there was still plenty of opportunity for us to increase our observed ranges on these plays since we began tracking them Wednesday morning:

UNH Weekly $270-277.50 Calls
$270: 6.00-26.50 (+342%)
$272.50: 4.21-26.00 (+518%)
$275: 3.30-20.00 (+506%)
$277.50: 2.39-21.40 (+795%)

_____

Johnson & Johnson JNJ –  We’ve also been following the JNJ 09/18 $150-155 Calls since last Tuesday morning, and like the play above, are returning for the second straight day to highlight the impressive gains we’ve witnessed thus far:

  JNJ 09/18 $150-155 Calls
$150: 2.90-10.17 (+251%)
$155: 2.27-7.50 (+230%)
____

The success with our options calls just kept coming this week, and that includes a pair of our ideas that were fresh for yesterday morning. We signaled interest in calls in the ABT and TSM chains, and saw some really nice moves there as well.

ABT Weekly $90-92.50 Calls
$90: 2.00-7.10 (+255%)
$92.50: .85-5.00 (+488%)
_____

TSM Weekly $50-52 Calls
$50: 1.86-3.16 (+70%)
$50.50:1.55-2.50 (+61%)
$51: 1.30-2.15 (+65%)
$51.50: .57-1.70 (+198%)
$52: .65-1.26 (+94%)

_____

More Fresh Ideas: 
STT Weekly $60-65 Calls*
KSU Weekly $136-140 Calls*

*Never trade options with a weekly expiration on Friday unless you’re an expert level trader with access to disposable funds!

Moderna Inc. MRNA

We began tracking MRNA at the end of February, initially tagging the stock on February 27th and then again on March 16th. After seeing a low of 19.31 following that report, MRNA has been making steady headway in its run up the chart which has persisted for more than a month now.

Yesterday we saw a new recorded high of 41.55, which represents an overall increase of 115% since we began following the activity in MRNA.

Extended Watchlist:
CBDL, TURV, CNBX, DECN, GLGI, PWRMF, SBES, PCTL

Coronavirus Watchlist & More

Todos Medical, Ltd. TOMDF

The see-saw of market volatility persists with no end in sight. Traditional investing has become a fool’s errand in many, if not most, cases. The kind of opportunistic short term trading that we do is relatively intact, with the right targets and scenarios.

In this case, we caught TOMDF’s coronavirus news in the premarket yesterday, stating that the company had secured distribution agreements for testing kits in both the US and Isreal. After including it in our extended watchlist, the stock managed a very nice intraday gain. It traded up from a low of  0413, and reached a high of .08, which works out to an intraday upswing of 94%

Coronavirus Watchlist

While we do focus primarily on quick strike opportunities, it’s also worth it to mention a few plays that represent products and services that are high demand at the present time due to the fallout from COVID-19. If the report from the UK’s highly respected Imperial College is accurate, this global health crisis is only in its beginning stages, and will get much, much worse in the months ahead.

While neither these, nor any other plays are “corona-proof”, the effects may weigh less heavily on these stocks and those like them:

CPB, APRN, CLX, GIS, PG

Extended Watchlist:
MATN, ZOOM, DECN, PCTL, NBDR, IPIX, GNPX, GNBT

BYND Update & More

Beyond Meat, Inc. BYND – Update

On Wednesday morning, we put a few options ideas on the radar in our premarket report, for the BYND chain. We signaled some weekly sets as well as one that expires at the end of next week. Our specific ideas were the BYND Weekly $86-88 Calls & 01/24 $95 Calls.

Despite a down day for the markets, BYND continued its impressive run, just in terms of the stock itself, which made a move from  81.16-97.90 between Wednesday and Friday. That alone works out to a modest, yet notable, increase of 21%, a figure which is rising as we speak, having breached $100 here in the premarket.

The moves produced by the calls we highlighted also enabled some fantastic gain opportunities for ourselves and our readers:

BYND Weekly $86-88 Calls
$86: 1.43-12.30 (+760%)  
$87: 1.42-11.50 (+710%)
$88: 1.24-10.45 (+743%)

BYND 01/24 $95 Calls
$95: .85-7.15  (+741%)  

ContraFect Corp. CFRX

CFRX, which we signaled for observation in our report from December 17th, has continued the impressive run it has been on ever since our initial alert.

We witnessed shares changing hands for as little as .38 and the progress it has made is really great. On Friday, the stock registered a new high of 1.15, representing a roughly three-week upswing of 203%

Extended Watchlist:
DMAN, PCTL, HENC, GGSM